SEARCH SITE

VIRGINIA LAW PORTAL

SEARCHABLE DATABASES

ACROSS SESSIONS

Developed and maintained by the Division of Legislative Automated Systems.

2023 SESSION

  • | print version

HJ 544 Alzheimer's Disease; Joint Commission on Health, etc., to study treatment.

Introduced by: Elizabeth R. Guzman | all patrons    ...    notes | add to my profiles

SUMMARY AS INTRODUCED:

Study; Joint Commission on Health Care; Alzheimer's Disease and Related Disorders Commission; treatment of Alzheimer's disease; report. Directs the Joint Commission on Health Care and the Alzheimer's Disease and Related Disorders Commission (the ADRD Commission) to study the treatment of Alzheimer's disease. The resolution directs the Joint Commission and the ADRD Commission to analyze the following as they relate to the treatment of and medication for patients with Alzheimer's disease: (i) continuing medical education requirements for physicians, (ii) public health education for patients and caregivers, (iii) Commonwealth Alzheimer's disease plans and the inclusion of the latest treatment and medication in such plans, (iv) access to screening and diagnostic tools and coverage of such tools by insurance plans, (v) access to therapeutics and coverage of such therapeutics by insurance plans, and (vi) Medicaid coverage for approved drugs. The resolution requires the Joint Commission and the ADRD Commission to complete their meetings by November 30, 2023, and submit their findings and recommendations no later than the first day of the 2024 Regular Session of the General Assembly.


FULL TEXT

HISTORY